Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

New York, NY (December 10, 2022) — A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. The…#florida #usnewsworldreport #honorrollhospital #ash #ny #neurologyneurosurgery #geriatrics #journalnewenglandjournalofmedicine #twitter #ajaichari
Source: Reuters: Health - Category: Consumer Health News Source Type: news